Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) is a blank-check special purpose acquisition company formed to pursue a business combination in the biotechnology and life sciences sector. The company filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 22, 2022, under accession number 0001213900-22-074335, documenting its financial position and operational status as a pre-combination SPAC. BIOT's sector focus places it among a cohort of life-sciences-targeted vehicles that were active on public markets during a period of significant SPAC deal activity. Sponsor details and full IPO vintage data are available on the platform. Sign up at SpacDesk for complete filing history, deal timelines, and deeper analytics on BIOT and every active SPAC in the market.